Viewing Study NCT05734105

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:13 AM
Ignite Modification Date: 2026-06-30 @ 10:44 PM
Study NCT ID: NCT05734105
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-17
First Post: 2023-02-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib
Sponsor: Deciphera Pharmaceuticals, LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None GIST View
Keywords:

Keywords

Keyword Brief Keyword Text View
None advanced gastrointestinal tumors View
None gastrointestinal stromal tumors View
None imatinib View
None ripretinib View